[急性间歇性炎和汉塔病毒感染]
Deutsche medizinische Wochenschrift (1946)
|November 10, 2023
概括
急性间歇性炎 (AIN) 是一种导致急性损伤的炎. 虽然药物诱导的AIN是常见的,但像病流行病 (NE) 这样的感染也会引起它,有很好的恢复机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性间歇性炎 (AIN) 是急性损伤 (AKI) 的重要原因,其特征是管间歇性炎症.
- 常见的病因包括药物 (抗生素,PPI,NSAID),自身免疫性疾病和感染.
- 由Puumula病毒 (PUUV) 感染引起的流行性病 (NE) 是AIN的一个显著的传染病原因,特别是在欧洲.
研究的目的:
- 审查急性间歇性炎的原因,临床表现和管理.
- 要突出与药物相关的AIN与像NE这样的传染病引起的不同特征和预后.
主要方法:
- 对AIN病因的文献综述,重点关注药物诱导和传染病因.
- 对AIN的临床特征,诊断挑战和治疗策略的分析.
- 对不同AIN亚型的结局结果进行比较,包括药物诱导和NE.
主要成果:
- 药物诱导的AIN经常与抗生素,PPI和NSAIDs有关,尽管皮疹,发烧和eosinophilia的经典三位一体是罕见的.
- 流行性病症呈现为伴有发烧和血小板衰竭的AIN,起源于动物传播的PUUV感染.
- 在NE后,功能完全恢复是常见的.
结论:
- 停止使用违规药物是治疗药物相关的AIN的基石;在严重的情况下,可以使用葡萄糖皮质激素.
- 由于NE导致的AIN具有普遍有利的预后,具有完全恢复功能的良好机会.
- 了解各种病因对于及时诊断和适当管理AIN至关重要.
相关概念视频
01:27Acute Pyelonephritis I: Introduction
20
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
20
01:29Acute Kidney Injury II: Pathophysiology
9
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
9
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
15
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
15
01:25Antihypertensive Drugs: Direct Renin Inhibitors
648
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
648
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
18
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
18
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438